Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Amazon Explores AI Content Marketplace With Media Publishers 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
CHICAGO, Feb. 20, 2018 -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of Scott A. Falk, MD, to the firm’s Physician Advisory Council.
A practicing anesthesiologist and critical care physician, Dr. Falk serves as Director of Performance Improvement, Quality and Safety at Penn Medicine (University of Pennsylvania). He is also an Associate Professor of Clinical Anesthesiology and Critical Care at the University of Pennsylvania. He brings a wealth of experience, including past positions as post-anesthesia care unit (PACU) and surgical intensive care unit (SICU) medical director, and years of experience improving healthcare value and outcomes.
“Our Physician Advisory Council uniquely enables us to foster alignment between physicians and hospital leaders with insights from practicing clinicians,” said Lumere CEO Hani Elias, JD, MPH. “With Dr. Falk’s background, we’re now able to provide even more in-depth guidance to our clients as they tackle issues related to device and drug selection for anesthesiology and critical care, two areas that offer significant opportunities.”
According to Dr. Falk, he’s eager to help Lumere’s clients optimize patient care. “Healthcare costs have been spiraling out of control for a number of years, partly due to the vast array of devices and therapies we have to choose from,” he said. “However, the reality is that patient outcomes have not improved at the same pace. Lumere allows physicians to work with their hospitals to refocus on providing the right solutions and making the best decisions about patient care.”
Dr. Falk joined the faculty of Penn Medicine in 2006. He received his medical degree from The George Washington University School of Medicine and Health Sciences and completed his fellowship with the Clinical Clinic Foundation.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260
